Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Carotid Artery Stenting : A Vascular Surgeon‐Endovascular Specialist's Perspective

Carotid Artery Stenting : A Vascular Surgeon‐Endovascular Specialist's Perspective Endovascular interventions were developed to provide minimally invasive alternatives to standard surgical therapies. Where an endoluminal technique has the potential to supplant its surgical predecessor, the rival must prove itself against the gold standard in terms of outcome, complications, and durability. In the case of carotid stenting, the stroke risk reduction data for carotid endarterectomy gathered from recent randomized trials appear to be unassailable. In the face of this challenge, why would we pursue an endoluminal alternative? Would the investment in resources and device development result in benefit to the patient? In this perspective, an endovascular surgeon proposes several possible case scenarios appropriate to carotid stenting and reviews progress to date on the investigation of this therapeutic alternative. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiology Wiley

Carotid Artery Stenting : A Vascular Surgeon‐Endovascular Specialist's Perspective

Loading next page...
 
/lp/wiley/carotid-artery-stenting-a-vascular-surgeon-endovascular-specialist-s-dZOYAAesLG

References (28)

Publisher
Wiley
Copyright
Copyright © 1996 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0896-4327
eISSN
1540-8183
DOI
10.1111/j.1540-8183.1996.tb00621.x
Publisher site
See Article on Publisher Site

Abstract

Endovascular interventions were developed to provide minimally invasive alternatives to standard surgical therapies. Where an endoluminal technique has the potential to supplant its surgical predecessor, the rival must prove itself against the gold standard in terms of outcome, complications, and durability. In the case of carotid stenting, the stroke risk reduction data for carotid endarterectomy gathered from recent randomized trials appear to be unassailable. In the face of this challenge, why would we pursue an endoluminal alternative? Would the investment in resources and device development result in benefit to the patient? In this perspective, an endovascular surgeon proposes several possible case scenarios appropriate to carotid stenting and reviews progress to date on the investigation of this therapeutic alternative.

Journal

Journal of Interventional CardiologyWiley

Published: Jun 1, 1996

There are no references for this article.